Emerging Potential Benefits of Modulating NAD+ Metabolism in Cardiovascular Disease.

about

Emerging Potential Benefits of Modulating NAD+ Metabolism in Cardiovascular Disease.

Item

http://www.wikidata.org/entity/Q49917755

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Emerging Potential Benefits of Modulating NAD+ Metabolism in Cardiovascular Disease.

@en

Emerging Potential Benefits of Modulating NAD+ Metabolism in Cardiovascular Disease.

@nl

type

Item

label

Emerging Potential Benefits of Modulating NAD+ Metabolism in Cardiovascular Disease.

@en

Emerging Potential Benefits of Modulating NAD+ Metabolism in Cardiovascular Disease.

@nl

prefLabel

Emerging Potential Benefits of Modulating NAD+ Metabolism in Cardiovascular Disease.

@en

Emerging Potential Benefits of Modulating NAD+ Metabolism in Cardiovascular Disease.

@nl

P1476

Emerging Potential Benefits of Modulating NAD+ Metabolism in Cardiovascular Disease.

@en

P2860

Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias

Cardiac Na+ current regulation by pyridine nucleotides

GPD1L links redox state to cardiac excitability by PKC-dependent phosphorylation of the sodium channel SCN5A

SIRT4 represses peroxisome proliferator-activated receptor α activity to suppress hepatic fat oxidation

SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells

Molecular and functional characterization of novel glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) mutations in sudden infant death syndrome

Mitochondrion as a Target for Heart Failure Therapy- Role of Protein Lysine Acetylation

Mechanisms of altered Ca²⁺ handling in heart failure

Mitochondrial protein acetylation as a cell-intrinsic, evolutionary driver of fat storage: chemical and metabolic logic of acetyl-lysine modifications

Nicotinamide riboside promotes Sir2 silencing and extends lifespan via Nrk and Urh1/Pnp1/Meu1 pathways to NAD+.

P31

scholarly article

P356

10.1152/AJPHEART.00409.2017

http://www.w3.org/2001/XMLSchema#string

P50

Charles Brenner

Barry London

Daniel S Matasic

P577

2017-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29351465

http://www.w3.org/2001/XMLSchema#string

P932

5966770

http://www.w3.org/2001/XMLSchema#string